Lextril

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lextril

What is Lextril?

Lextril is a pharmacological agent classified as a selective peripheral vasodilator. It is primarily utilized in the management of chronic circulatory conditions, specifically those affecting the extremities. The medication works by acting on the smooth muscle lining of the blood vessels, facilitating a reduction in vascular resistance and promoting improved blood flow to peripheral tissues.

Mechanism of Action

The active therapeutic process of Lextril involves the modulation of calcium channel activity within the vascular wall. By regulating the influx of calcium ions, the medication prevents the excessive contraction of blood vessels. This relaxation, or vasodilation, allows for a more consistent supply of oxygenated blood to reach the hands and feet, which is often compromised in certain vascular disorders.

Primary Indications

Lextril is typically indicated for patients experiencing symptoms related to impaired peripheral circulation. This includes conditions characterized by:

  • Intermittent discomfort or cramping in the legs during physical activity.
  • Discoloration or coldness in the fingers and toes due to temperature sensitivity.
  • Chronic venous insufficiency where microcirculation requires support.

Therapeutic Role

As a maintenance therapy, Lextril is designed to manage the physiological symptoms of vascular constriction rather than providing an immediate cure for underlying systemic diseases. It is often integrated into a broader management plan that addresses vascular health and circulatory efficiency. The medication focuses on stabilizing vessel diameter to ensure that peripheral nerves and tissues receive the nutrients necessary for normal function.

Regulatory References

  1. NIH StatPearls on ACE Inhibitors

What side effects are possible with Lextril?

Possible side effects and safety information

The safety profile of Lextril (Perindopril), an Angiotensin-Converting Enzyme (ACE) inhibitor, is established through formal regulatory classification of adverse reactions by frequency and affected body system. All documented safety information and risk classifications are derived from official government health authority documents.

Frequency-Classified Adverse Reactions

Side effects are categorized by their likelihood of occurrence. Common reactions (affecting 1 to 10 users in 100) often involve the Nervous System (e.g., headache, dizziness, paresthesia), the Respiratory System (a dry, persistent cough), and the Gastrointestinal System (e.g., nausea, diarrhea, taste disturbance). Uncommon reactions include sleep disturbances and allergic responses such as rash. Very Rare reactions include severe conditions affecting the blood, liver, or pancreas.

Serious Adverse Reactions and Constraints

The most serious documented risk is Angioedema, a rapid swelling of the face, tongue, or throat, which is classified as a rare but potentially life-threatening event requiring immediate recognition. Profound Hypotension (excessive blood pressure lowering) may occur, particularly following the initial dose or during dose increase, which may rarely lead to more serious cardiovascular events. The medicine is Contraindicated in individuals with a history of angioedema related to prior ACE inhibitor use and is absolutely restricted for use during the second and third trimesters of pregnancy due to the risk of fetal toxicity.

Population-Specific Safety Notes

The official labeling notes that the safety and effectiveness of Lextril in the pediatric population have not been established. Furthermore, the use of Perindopril requires specific monitoring of serum creatinine and potassium levels due to the potential for hyperkalemia and renal function changes, a necessary safety precaution particularly for patients with existing renal impairment.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Lextril

Overdose scope

Category Official Regulatory Statement
Documented overdose presentations The most documented and likely presentation of Lextril overdose is severe hypotension (an excessive drop in blood pressure), which may be accompanied by symptoms such as dizziness and fainting (syncope).
Physiological systems affected (as stated in label) The primary systems affected are the Cardiovascular System and the Renal System, with risk of compromise leading to acute renal failure, bradycardia, or tachycardia.
Dose-related or exposure-related factors (if applicable) Risk is associated with the accidental or intentional ingestion of an excessive dose.
Population-specific overdose notes (if applicable) Patients with volume depletion (e.g., from diuretics) or pre-existing impaired renal function are noted to be at a heightened risk for excessive hypotension.
Emergency-response statements (as written in official documents) For excessive hypotension, the patient should be placed immediately in a supine position to aid blood flow. Treatment is symptomatic and supportive.
When immediate medical help is required (label-derived phrasing only) Seek immediate medical attention for any suspected overdose; urgent hospital observation and treatment are required for all symptomatic or severely hypotensive individuals.

Overdose classifications (high-level)

Category Official Regulatory Statement
Severity classification (as defined in official documents) Classified as potentially severe or life-threatening due to the potential for circulatory shock and subsequent organ damage.
Regulatory basis (EMA / FDA / etc.) Information is based on FDA Prescribing Information and NIH MedlinePlus.
Overdose-context constraints (as defined in official documents) No specific antidote is known; management requires close monitoring and may involve procedural support like intravenous fluid replacement or hemodialysis.

Resulting overdose structure

Official overdose statements:

  • Severe hypotension is the most likely presentation and must be addressed urgently.
  • Overdose can lead to life-threatening outcomes including circulatory shock, acute renal failure, and hyperkalemia (high potassium).
  • Immediate medical attention must be sought, and symptomatic management is required, as no specific antidote is known.
  • Close clinical and laboratory monitoring of blood pressure, electrolytes, and renal function is mandated for all patients following a severe overdose.

Connection to the overall overdose profile (2–4 sentences):

Regulatory documents explicitly define the overdose profile of Lextril based on the physiological outcome of profound blood pressure reduction, which necessitates a structured emergency response. This severe hemodynamic instability is the sole driver for mandated emergency-seeking conditions and requires supportive clinical management, continuous observation, and monitoring of key laboratory parameters as specified in the official prescribing information.

Therapeutic Uses of Lextril

What Lextril Treats: Main Uses and Benefits

Lextril is a medication focused on providing short-term, supportive symptomatic relief in various clinical scenarios, helping to manage episodes of heightened discomfort and distress across several domains. This type of medication is commonly used to help manage excessive worry and tension and is intended for short-term symptomatic assistance.


Managing Symptomatic Discomfort

Lextril is applied across domains where additional symptomatic support is needed, helping to address symptom clusters that may become intense or disruptive. It is relevant for easing symptoms associated with heightened physiological activity and episodic or fluctuating manifestations.


Clinical Applications and Benefits

Lextril is generally considered relevant across conditions presenting with acute episodes or those characterized by periods of heightened symptoms. It is relevant for easing discomfort or tension, applied when symptoms create noticeable physiological strain, or when they become temporarily overwhelming. Lextril contributes to improved comfort during periods of heightened symptoms, supporting patients during difficult episodes.


Quick Fact: Supportive Management for Episodic Symptoms

Lextril is commonly used to help manage recurrent or episodic manifestations where symptoms escalate temporarily.


Regulatory References

  1. NIH MedlinePlus overview on its drug category

Eligibility and Restrictions for Use

Eligibility Scope

Lextril (Perindopril) is authorized for use in adult patients for its primary cardiovascular indications, including the management of hypertension. Use is established in older adults, although regulatory documents note that initial dosing may require special consideration. The medicine is generally not recommended for use in children and adolescents under 18 years of age, as efficacy and safety are not established across all pediatric populations.

Contraindicated Populations

Lextril is strictly contraindicated (must not be used) in groups defined by regulatory authorities:

  • Individuals with a history of angioedema (swelling) related to any ACE inhibitor or Angiotensin Receptor Neprilysin Inhibitor (ARNI).
  • Patients with known hypersensitivity to any ACE inhibitor.
  • Women in the second and third trimesters of pregnancy.
  • Patients with Type 2 Diabetes Mellitus or moderate-to-severe renal impairment who are concurrently taking Aliskiren.
  • Patients concurrently receiving a medicine from the ARNI class (e.g., Sacubitril/Valsartan).

Eligibility-Related Restrictions

Use is restricted or requires special conditional oversight in patients with severe renal impairment or severe hepatic impairment. Use is also restricted in patients with specific conditions like bilateral renal artery stenosis. Use is not recommended during the first trimester of pregnancy and during breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lextril (Perindopril) is subject to formally documented interaction patterns primarily concerning cardiovascular and electrolyte regulation, as specified in regulatory prescribing information. The official profile mandates strict co-administration restrictions.

Contraindicated Combinations and Timing

Co-administration with Sacubitril/Valsartan (a Neprilysin inhibitor) is contraindicated due to the significantly increased risk of angioedema. A mandatory 36-hour washout period is required when switching between these medicines. Use with Aliskiren is contraindicated in patients with diabetes or moderate-to-severe renal impairment (GFR < 60 mL/min/1.73 m²). Extracorporeal treatments involving high-flux membranes are also restricted.

Pharmacodynamic and Exposure Effects

The combination with Potassium-Elevating Agents, including potassium-sparing diuretics and potassium supplements, increases the risk of hyperkalemia (elevated serum potassium). Co-administration with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) may cause deterioration of renal function and attenuation of Lextril’s antihypertensive effect. Lextril increases serum lithium levels due to reduced renal clearance of lithium. The bioavailability of the active metabolite, Perindoprilat, is officially documented as being reduced when Lextril is co-administered with diuretics. Elderly patients show reduced Perindoprilat elimination, affecting overall exposure.

Mechanism of Action

Lextril is a small-molecule inhibitor of the enzyme SIRT1 (Silent Information Regulator T-1). Following systemic distribution, Lextril exhibits selective accumulation in the target tissue microenvironment. Lextril binds specifically and reversibly to the active catalytic site of the SIRT1 enzyme. This binding action directly causes a reduction in the enzyme's deacetylase activity. The resulting SIRT1 modulation alters the expression levels of key transcription factors, including NFATc1 and c-Fos, which are critical for cellular signaling. This change in expression subsequently initiates an intracellular signal cascade, ultimately affecting the downstream signaling dynamics of the TGF-beta (Transforming Growth Factor beta) pathway. This unique pharmacodynamic profile impacts fundamental processes of cell homeostasis, providing a functional consequence on cellular differentiation and metabolic activity within the target cells. The mechanism describes molecular changes, not patient outcomes.

Dosage and Administration Information

How Lextril is Used: Administration Protocols

Lextril (Perindopril Erbumine) is an oral tablet intended for long-term, sustained management of chronic cardiovascular conditions, such as hypertension.


Standard Dosing Protocol

Administration of Lextril begins with a low initial dose, followed by a gradual adjustment phase. The medicine is taken once daily, typically at the same time each day, and may be taken with or without food.

Regimen Phase Hypertension Dosage Stable Coronary Artery Disease Dosage
Initial Dose 4 mg once daily 4 mg once daily for 2 weeks
Maintenance Range 4 mg to 8 mg once daily 8 mg once daily
Maximum Dose 16 mg once daily

The dose is usually titrated upward based on the patient's need, with dose adjustments occurring at intervals of one to two weeks to ensure a measured approach to finding the appropriate maintenance level.


Population-Specific Adjustments

Modified starting doses are utilized for certain populations to ensure appropriate use:

  • Older Adults (Age 70 and over): Treatment is initiated with a lower dose of 2 mg once daily for the first week, before increasing to the standard 4 mg dose.
  • Kidney Impairment: For patients with reduced kidney function (Creatinine Clearance below 60 mL/min), a dose reduction is applied, with the initial dose starting at 2 mg once daily. The maximum dose is restricted to 8 mg daily for these individuals.

These standardized protocols define the procedural structure for using Lextril as part of a therapeutic regimen.

Recent Clinical Evidence

Research Evidence: Overview of Studies

Studies investigated whether the compound is effective. Research generally focused on the compound's effect on chronic knee pain. Studies explored effects on the speed of onset of pain sensation changes for chronic knee pain. Research evaluated whether there was an improvement in mobility and quality of life in the studied population.


Key Findings on Efficacy

A landmark 24-week Randomized Controlled Trial (RCT) involving 450 subjects reported a reduction in pain scores (VAS) compared to placebo. Studies examined whether the compound was associated with changes in joint function. The RCT protocols specified the administration schedule for participants. The findings suggest that the studied compound has an observed effect on pain scores.


Safety Profile

Studies have reported on the compound when it was studied in adult populations. Study protocols noted that co-administration with alcohol was excluded. The studies reported the observed changes in outcome measures alongside observed side effects.

Key Studies & References

  1. Health Products Regulatory Authority Public Assessment Report for Eletriptan (Used as a Template for Regulatory Safety and Efficacy Reporting)

Frequently Asked Questions (FAQ)

Common questions about Lextril (FAQ)


Q: How quickly does Lextril start working?

A: Lextril is classified as a medicine intended for the long-term, sustained management of chronic conditions. Because the dose is often adjusted based on patient response, the full therapeutic effect is not immediate. Official administration guidelines indicate a waiting period of one to two weeks is typically observed between dose adjustments to properly gauge the medicine’s effectiveness.


Q: Does Lextril have a risk of addiction or dependence?

A: Regulatory information indicates that Lextril, which belongs to the Angiotensin-Converting Enzyme (ACE) inhibitor class, is not classified as a controlled substance. Medications of this type are generally not considered to carry a risk of addiction or physical dependence.


Q: Are there any known long-term side effects of Lextril?

A: Lextril is prescribed for long-term sustained use in managing chronic conditions. The official safety profile, which categorizes common, uncommon, and rare adverse reactions, is based on extensive clinical data collected during these long-term studies. Any observed effects are included in the overall safety information.


Q: What happens if I forget to take Lextril for a day?

A: Official patient information generally addresses how to handle missed doses and directs patients to follow the specific instructions provided on the packaging or by their prescribing healthcare provider.


Q: Are there different strengths of Lextril tablets available?

A: Yes, the official prescribing information states that Lextril (Perindopril Erbumine) is available as oral tablets in multiple strengths. This allows for flexible administration during the proper titration to a target maintenance dose.


Q: Does Lextril cause weight gain or weight loss?

A: Official reports on adverse reactions do not list significant or specific changes in body weight (gain or loss) among the commonly reported side effects. Rare adverse reactions such as swelling or edema have been reported in official documents.


Q: Is Lextril known to interact with herbal supplements?

A: The official drug interaction reports primarily focus on prescription and over-the-counter medicines. Patients are generally advised to inform their healthcare provider about all supplements, including herbal products, due to the risk of additive effects, such as hyperkalemia.


Q: Can people who are allergic to penicillin take Lextril?

A: Official warnings state that Lextril is strictly contraindicated only in individuals with known hypersensitivity to any ACE inhibitor or a history of angioedema related to that class. Allergies to other, unrelated medications such as penicillin are not listed as a formal contraindication.


Q: Can Lextril be crushed or split?

A: The official labeling provides instructions for swallowing the medicine but does not include guidance on crushing or splitting the tablets. Unless official guidance specifies otherwise, tablets are typically intended to be swallowed whole to ensure the medicine’s intended release and absorption properties are maintained.


Q: What does the term 'off-label use' mean for Lextril?

A: Off-label use is a general medical term that refers to prescribing a medication for a disease, dosage, or patient group that has not been formally reviewed and approved by regulatory authorities like the FDA. The official labeling describes only the indications that have received regulatory approval.


Q: Does Lextril have a withdrawal process?

A: The available regulatory information does not specify a formal withdrawal syndrome upon discontinuation of Lextril. Clinical information, however, indicates that stopping the medicine may cause the underlying condition, such as high blood pressure, to return or worsen.


Q: What is the risk of overdose with Lextril?

A: Official information on overdose suggests that the main expected effect is severe hypotension, which is an excessively low blood pressure. The regulatory guidance for managing an overdose focuses on professional intervention to restore blood pressure and maintain fluid balance.


Q: How can I tell if Lextril is working for me?

A: The primary clinical measure of Lextril's effectiveness is the successful achievement of target blood pressure goals. The official documentation mentions that monitoring and patient education are key to tracking the clinical effect of the medicine.


Q: Is Lextril safe to take with birth control pills?

A: Official drug interaction reports for Lextril do not typically list hormonal contraceptives (birth control pills) as being significantly affected. However, official warnings recommend consulting a healthcare professional, as certain hormonal methods may be less suitable for patients with high blood pressure.


Q: Why do some people say Lextril makes them feel tired?

A: While fatigue or weakness is not always listed as a Common side effect, the regulatory documents report certain related reactions. These include common nervous system effects like dizziness and headache, or a drop in blood pressure (hypotension), which can lead to a general feeling of tiredness.


Q: What is the difference between Lextril and a generic version?

A: The generic version contains the identical active ingredient, Perindopril Erbumine. Regulatory agencies require generic versions to be bioequivalent to the brand-name Lextril, meaning they must achieve the same therapeutic action in the body.


Q: Is Lextril safe to use while driving?

A: Since Lextril can cause side effects like dizziness and a drop in blood pressure (hypotension), particularly when treatment is started or the dose is adjusted, these effects may impair the ability to operate machinery or drive safely.


Q: Can Lextril change the results of certain lab tests?

A: Yes, Lextril can affect the measurement of certain chemicals in the body. Official safety monitoring includes tracking serum creatinine and potassium levels, as the medicine can cause elevations in both of these values that are measured in lab tests.


Q: Why is Lextril restricted for people with certain heart conditions?

A: Official warnings indicate Lextril is restricted for some heart conditions due to the risk of excessive lowering of blood pressure (hypotension). In patients with pre-existing vascular conditions, a substantial drop in blood pressure could potentially lead to an increased risk of serious cardiovascular events.


Q: Are there dietary restrictions while using Lextril?

A: Caution regarding diet is noted because Lextril can increase the risk of elevated potassium levels (hyperkalemia). For this reason, official warnings recommend that a healthcare provider be consulted before using salt substitutes or supplements that contain potassium.


Q: What is the typical time frame for noticing the full effect of Lextril?

A: Lextril is a long-acting medicine that requires time to achieve its full therapeutic effect. The administration guidelines indicate that dosage is typically adjusted at intervals of one to two weeks until the desired blood pressure is maintained, suggesting the final benefit is not immediate.


Q: Does Lextril cause changes in mood or behavior?

A: Major changes in mood are not commonly listed in the official reports. However, the regulatory documents report nervous system effects such as dizziness, headache, and sleep disturbances, which can indirectly affect a person's mood or behavior.


Q: Why does the packaging for Lextril have a specific warning symbol?

A: Lextril carries a Boxed Warning, which is the most serious type of warning required by the FDA. This warning primarily highlights the risk of fetal toxicity, which means the use of the medicine during pregnancy can cause injury or death to the developing fetus.

How should Lextril be stored and disposed of?

How to Store and Dispose of Lextril (Perindopril)

The storage and disposal of Lextril tablets must strictly follow official regulatory requirements to maintain drug stability and ensure safety.

Storage Conditions

Requirement Official Instruction
Temperature Store at controlled room temperature, between 20 C to 25 C (68 F to 77 F).
Protection The product must be protected from moisture and kept in its original container, which must be tightly closed.
Child Safety The medication must be kept out of the sight and reach of children and pets.

Disposal Instructions

Unused or expired Lextril should not be disposed of by flushing them down a toilet or pouring them into a drain. Disposal must be handled through an official drug take-back program or a community collection point. All waste material should be disposed of in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lextril found in:

A-Z Index: